ProShares Nanotechnology Ownership

TINY
 Etf
  

USD 30.97  0.26  0.83%   

Some institutional investors establish a significant position in etfs such as ProShares Nanotechnology in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of ProShares Nanotechnology, and when they decide to sell, the etf will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Additionally, take a look at World Market Map.
  
ProShares Nanotechnology Price to Book Value is fairly stable at the moment as compared to the past year. ProShares Nanotechnology reported Price to Book Value of 2.53 in 2021. Price to Sales Ratio is likely to rise to 88.27 in 2022, whereas Return on Investment is likely to drop (4.25)  in 2022.
ProShares Nanotechnology owns a total of thirty-one million one hundred seventy-four thousand seven hundred fifty-eight outstanding shares. 30% of ProShares Nanotechnology ETF outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company maintains, if the real value of the etf is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

ProShares Etf Ownership Analysis

ProShares Nanotechnology is is formed as Regulated Investment Company in the United States. ETF is managed and operated by J.P. Morgan Chase Bank, N.A.. The fund has null constituents with avarage daily trading value of 0.0. The fund charges 0.58 percent management fee with total expences of 0.58 percent of total asset. The fund maintains 99.7% of assets in stocks. The index consists of companies focused on making or applying nanotechnology innovations that allow for improved products, processes, or techniques through control or measurement of material at nanoscale. Proshares Nanotechnology is traded on NYSEARCA Exchange in the United States. To find out more about ProShares Nanotechnology ETF contact Douglas Jamison at NA or learn more at www.180degreecapital.com.

Sector Exposure (%)

Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on ProShares Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding ProShares Nanotechnology , and the less return is expected.

ProShares Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as ProShares Nanotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ProShares Nanotechnology ETF backward and forwards among themselves. ProShares Nanotechnology's institutional investor refers to the entity that pools money to purchase ProShares Nanotechnology's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Ubs Group AgFund Units307K
Note, although ProShares Nanotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ProShares Nanotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Currently Active Assets on Macroaxis

Additionally, take a look at World Market Map. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for analysis

When running ProShares Nanotechnology price analysis, check to measure ProShares Nanotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProShares Nanotechnology is operating at the current time. Most of ProShares Nanotechnology's value examination focuses on studying past and present price action to predict the probability of ProShares Nanotechnology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ProShares Nanotechnology's price. Additionally, you may evaluate how the addition of ProShares Nanotechnology to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
The market value of ProShares Nanotechnology is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Nanotechnology's value that differs from its market value or its book value, called intrinsic value, which is ProShares Nanotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Nanotechnology's market value can be influenced by many factors that don't directly affect ProShares Nanotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Nanotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine ProShares Nanotechnology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Nanotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.